Clinical characteristics and post-operative outcomes in children with malformation of cortical development related drug-resistant epilepsy: 428 cases in one pediatric epilepsy center

CNS Neurosci Ther. 2024 Sep;30(9):e70031. doi: 10.1111/cns.70031.

Abstract

Aims: To investigate post-operative seizure outcomes, and predictors of surgical outcomes of the malformation of cortical development (MCD) in children with drug-resistant epilepsy (DRE) and age-specific characteristics.

Methods: We retrospectively analyzed clinical data from 428 children with MCD-related DRE who underwent curative surgical treatment. Statistical analyses were conducted to identify correlative characteristics, prognostic predictors, and differences among various age groups.

Results: After more than 3 years of follow-up, 81.3% of patients achieved Engel I outcomes. Prognosis was correlated with factors such as age at surgery, MRI findings, invasive EEG, pathology, acute postoperative seizures (APOS), and the number of preoperative and postoperative anti-seizure medications (AEDs). Age at surgery and the number of preoperative AEDs (p < 0.001) were significant predictors of seizure recurrence. Distinct clinical characteristics were observed among different age groups.

Conclusion: Surgery is effective in terminating MCD-related DRE. Younger age at surgery and fewer preoperative AEDs are associated with better prognoses. Clinical characteristics vary significantly with age.

Keywords: children; different age; drug‐resistant epilepsy; malformation of cortical development; surgery.

MeSH terms

  • Adolescent
  • Anticonvulsants / therapeutic use
  • Child
  • Child, Preschool
  • Drug Resistant Epilepsy* / surgery
  • Electroencephalography / trends
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Magnetic Resonance Imaging
  • Male
  • Malformations of Cortical Development* / complications
  • Malformations of Cortical Development* / diagnostic imaging
  • Malformations of Cortical Development* / surgery
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anticonvulsants